AzTrials
AzTrials

SleepNCT04984824

Effects of Varying Duration of Naps on Cognitive Performance and Memory Encoding

A study testing Nap duration in people with Sleep, run by Duke-NUS Graduate Medical School at 1 site in Singapore.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To evaluate the nap duration that achieves maximal cognitive gain with practicality of implementation, the present work employs a within-subject design comparing nap durations of 10 minutes, 30 minutes, and 60 minutes with a no nap condition on benefits to alertness, vigilance, mood, speed of processing and memory… Read more about this study

Who is it for?
Ages 21 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Sleep
What is being tested?
Nap duration
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteSingapore
Study dates
1 Nov 2020to 15 Jun 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Participants aged from 21 - 35 years and who have an average sleep duration of 6-6.5 h are eligible for this study.

Who cannot join

  • Participants who have an average sleep duration of less than 6 h or more than 6.5 h, who report sleep apnea symptoms, who report drinking more than 5 cups of caffeinated drinks a day, who have a BMI greater or equal to 30, or report elevated depression or anxiety symptoms will be excluded.

Trial locations and contacts

1 site in 1 country.

Singapore1 site
  • Yong Loo Lin School of Medicine

    Singapore, 117549

Other trials in Singapore

About this study

Official title: Comparing the Effects of 10, 30 and 60 Minute Naps on Cognitive Performance and Memory Encoding

To evaluate the nap duration that achieves maximal cognitive gain with practicality of implementation, the present work employs a within-subject design comparing nap durations of 10 minutes, 30 minutes, and 60 minutes with a no nap condition on benefits to alertness, vigilance, mood, speed of processing and memory over post-nap intervals of 5 minutes, 30 minutes, 60 minutes and 240 minutes. The effect of nap duration on memory encoding will also be examined.

Read the detailed description

Naps are a global phenomenon and a commonly adopted lifestyle countermeasure to reduce sleepiness and performance impairments. Experimental studies have also shown that naps can improve cognitive functioning and enhance memory and mood. However, the implementation of naps is highly varied amongst individuals, and it remains uncertain what duration of naps achieves the greatest cognitive benefit. Given the potential for naps to boost productivity in societies such as ours where insufficient nocturnal sleep is prevalent and where work hours are long, an investigation of the optimal nap duration is warranted.

Previous studies suggest that the benefits of brief naps (5-15 minutes) occur immediately after the nap and last a limited period (1-3 hours). Longer naps (>30 minutes) are more likely to produce some temporary decrements due to sleep inertia but have the potential to improve cognitive performance for a more sustained period. These findings need to be strengthened through replication and extended to include memory measures that are evaluated over a longer post-nap testing period. To evaluate the nap duration that achieves maximal cognitive gain with practicality of implementation, the present work employs a within-subject design comparing nap durations of 10 minutes, 30 minutes, and 60 minutes with a no nap condition on benefits to alertness, vigilance, mood, speed of processing and memory over post-nap intervals of 5 minutes, 30 minutes, 60 minutes and 240 minutes. The effect of nap duration on memory encoding will also be examined.

The investigator's findings are expected to inform theoretical models of sleep and cognition and will aid in the design of practical lifestyle strategies to alleviate sleepiness and improve cognitive performance that may be adopted in an everyday context to boost societal well-being and productivity.

Conditions
Sleep
Being tested
Nap duration

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Nap durationBehavioural

    A cognitive battery which will be repeated at 1505, 1530, 1600 and 1900. Material for the picture encoding task will be learned at 1630 and will be tested at 2000.

Study groups in NCT04984824
Study groupRoleWhat they receive
No nap groupNo interventionNo nap opportunity will be given in this condition.
10 minute napExperimentalParticipants will be given a 10 minute nap.
Receives: Behavioral: Nap duration
30 minute napExperimentalParticipants will be given a 30 minute nap.
Receives: Behavioral: Nap duration
60 minute napExperimentalParticipants will be given a 60 minute nap.
Receives: Behavioral: Nap duration

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Picture encoding task

    Participants will observe pictures of non-famous people, landscapes, scenes and objects. Later they are tested on whether they remember seeing the picture previously or not. The encoding session will take 20-30 min, and the retrieval session will take 15 min.

    Measured: In total: 35-45 min

  2. Levels of sleepiness

    Karolinska Sleepiness Scale. Participants rated their level of subjective sleepiness on a 9-point Likert scale (1 - very alert, 9 - very sleepy, great effort to keep awake).

    Measured: 1 min

  3. Mood

    Positive and Negative Affect Scale. On the Positive and Negative Affect Scale (PANAS), participants responded to 20 adjectives describing positive and negative mood states on a 5-point Likert scale (1 - very slightly, 5 - extremely). Positive and negative affect scores are represented by the sum of the item responses.

    Measured: 1 min

  4. Vigilance

    Psychomotor Vigilance Test. The 3-min PVT assessed levels of sustained attention. At intervals varying randomly from 2000 ms to 10000 ms, a counter on the screen appeared and participants were to press a key as quickly as possible. Lapses were defined as responses exceeding 500 ms.

    Measured: 3 min

  5. Speed of processing

    Digit Symbol Substitution Test. The 2-min DSST was used as a measure of speed of processing. In this task, participants were required to match symbols to digits as quickly as possible following a key shown on screen. The total number of correct trials was used as the critical measure.

    Measured: 2 min

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Aug 2021
  2. Study start1 Nov 2020
  3. Primary completion15 Jun 2021
  4. Study completion15 Jun 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04984824
Sponsor's protocol ID
NapTitration
Status last verified
Jul 2021
First submitted
15 Mar 2021
Last updated
2 Aug 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Leong RLF, Lau T, Dicom AR, Teo TB, Ong JL, Chee MWL. Influence of mid-afternoon nap duration and sleep parameters on memory encoding, mood, processing speed, and vigilance. Sleep. 2023 Apr 12;46(4):zsad025. doi: 10.1093/sleep/zsad025.

    PubMed 36775965

Questions about this trial

What is this clinical trial studying?

A study testing Nap duration in people with Sleep, run by Duke-NUS Graduate Medical School at 1 site in Singapore.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Picture encoding task (time frame: In total: 35-45 min). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04984824, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Aug 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in